PURE Bioscience (OTCMKTS:PURE – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.06 and traded as high as $0.07. PURE Bioscience shares last traded at $0.0627, with a volume of 49,975 shares changing hands.
PURE Bioscience Price Performance
The company has a fifty day moving average price of $0.07 and a 200 day moving average price of $0.06. The company has a market cap of $8.15 million, a PE ratio of -2.09 and a beta of 0.22.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its earnings results on Monday, June 15th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.51 million for the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Read More
- Five stocks we like better than PURE Bioscience
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
- MarketBeat Week in Review – 07/06 – 07/10
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
